| Arthritis drug found to work -- maybe too well - Chicago Sun-Times http://www.suntimes.com/lif... Arthritis Articles An experimental pain reliever from Pfizer Inc. significantly reduces joint pain in people with knee arthritis, according to research published Wednesday in the New England Journal of Medicine. But further studies on the drug, tanezumab, have been suspended ... |
| AstraZeneca Starts Enrollment For Phase III Clinical Trial Of Fostamatinib For Rheumatoid Arthritis - RTT News http://www.rttnews.com/Cont... Arthritis Articles (RTTNews) - British pharmaceutical company AstraZeneca plc (AZN: News ,AZN.L: News ) Wednesday announced the enrollment of the first patient for the phase III clinical development program called Oral Syk Inhibition in Rheumatoid Arthritis or OSKIRA for ... |
| How breast cancer drug causes arthritis in some women - New Kerala http://www.newkerala.com/ne... Arthritis Articles Washington, Sep 28 : Researchers at Mayo Clinic have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt ... |
| AstraZeneca says arthritis drug met goal in trial - Yahoo Finance http://finance.yahoo.com/ne... Arthritis Articles NEW YORK (AP) -- AstraZeneca PLC said Wednesday that its drug candidate fostamatinib met its goal in a midstage trial, as it worked better than a placebo at treating symptoms ... AstraZeneca, which is based in London ... |
| AstraZeneca (AZN) Announces Positive Data from Fostamatinib in Patients with RA Who Didn't Respond to MTX - StreetInsider.com http://www.streetinsider.co... Arthritis Articles AstraZeneca's (NYSE: AZN ) announced that fostamatinib (R788) showed improved results in patients with rheumatoid arthritis (RA) who responded inadequately to ongoing treatment with methotrexate (MTX), according to phase II study data published in The New ... |